TNXP | Tonix Pharmaceuticals HoldingNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$5.19
+$0.04 (+0.78%)

Tonix Pharmaceuticals Holding (TNXP) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.

The 50 SMA has sat below the 200 on the daily since Oct 2025, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $5.19 vs 50 $9.24 / 200 $12.36
Projection
No cross projected
Test
No active test
Last cross
Death cross 24 Oct 2025 ยท projected 13 bars out

4-hour as of 3 Nov 16:00 ET

Price
below both $5.19 vs 50 $6.49 / 200 $10.53
Projection
No cross projected
Test
No active test
Last cross
Death cross 28 Sep 2026 ยท projected 23 bars out

Cross history

15
crosses on record since 2018
7 golden8 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
28 Sep 2026Death4-hour23 bars outNot tested
3 Sep 2026Golden4-hour18 bars out3 bar cross test
24 Oct 2025Death steepdaily13 bars outNot tested
17 Sep 2025Death4-hour30 bars outโ€”
29 May 2025Golden moderatedaily17 bars outNot tested

About TNXP

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$5.3M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandmicro

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.